Drugs / TT-01025-CL
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04730050 | Feb → Dec 2021 | — | LG Chem | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TT-01025-CL | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04730050 ↗ |
| Route | Oral | “Oral tablet” NCT04730050 ↗ |